Related Experiment Video
Updated: Jun 10, 2025

Performing Colonoscopic-Guided Pinch Biopsies in Mice and Evaluating Subsequent Tissue Changes
Published on: February 5, 2021
Mucosal Cytokine Expression Associated With Deep Endoscopic Mucosal Healing in Ulcerative Colitis.
Kazuhiko Uchiyama1, Tomohisa Takagi1,2, Katsura Mizushima3
1Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
This study measured mucosal cytokines in ulcerative colitis (UC) patients, finding specific cytokines correlate with endoscopic healing. These findings may help identify molecular markers for nonrelapsing mucosal healing in UC.
Area of Science:
- Gastroenterology
- Immunology
- Molecular Biology
Background:
- Ulcerative colitis (UC) is a chronic inflammatory bowel disease with unknown etiology and no cure.
- Cytokines are implicated in UC pathogenesis, and targeted therapies show promise for refractory cases.
- Identifying mucosal cytokines linked to nonrelapsing mucosal healing (MH) is crucial for treatment development.
Purpose of the Study:
- To quantify mucosal cytokines in UC patients.
- To correlate cytokine expression with endoscopic findings of mucosal healing.
- To identify specific cytokines as potential biomarkers for MH in UC.
Main Methods:
- Prospective observational study of 163 UC patients.
- Endoscopic evaluation using Mayo Endoscopic Subscore (MES) and linked color imaging (LCI).
- Quantification of cytokine mRNA expression via real-time PCR in biopsy tissue, correlated with endoscopic data.
Main Results:
- Elevated levels of IFNγ, IL-1β, IL-8, IL-17A, and IL-23 correlated with endoscopic severity (MES and LCI).
- Distinct cytokine profiles (IL-22, IL-33) were observed between MES and LCI classifications based on disease severity.
- RNA sequencing revealed IL-5 and IL-6 involvement in subtle endoscopic redness differences in patients with MES 0.
Conclusions:
- This study establishes a correlation between mucosal cytokine expression and MH pathogenesis in UC.
- Specific cytokines may serve as valuable molecular markers for MH in UC.
- Findings support targeting specific cytokines for improved therapeutic strategies in UC.
More Related Videos
07:05Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
Published on: May 12, 2019
09:42Murine Endoscopy for In Vivo Multimodal Imaging of Carcinogenesis and Assessment of Intestinal Wound Healing and Inflammation
Published on: August 26, 2014
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors